Facebook Pixel 13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors | Bio Spectrum - business - Read this story on Magzter.com

Try GOLD - Free

13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors

Bio Spectrum

|

September 2024

The 13th edition of Bengaluru INDIA NANO 2024, organised by the Department of Science & Technology, Government of Karnataka, Karnataka Science & Technology Promotion Society (KSTePS), and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) concluded on August 3 with participation of 1018 delegates, 11 countries including Korea, Morocco, USA, UK, France, Canada, Germany, Netherlands, Russia, Japan, and Poland, 49 exhibitors comprising 21 startups and 28 industry and institutes, and 200 posters. The exhibition had a footfall of 3,000+ visitors.

13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors

The conference featured 81 distinguished speakers across 41 sessions, exploring a broad range of topics from cutting-edge research to practical industry applications in nanotechnology. Over 200 young attendees participated in the pre-conference tutorials.

During the two days sessions on "Nano in Healthcare", Prof. Dhirendra Katti, Director, IIT Goa spoke on 'Development of a Vaccines/Nano vaccines for Multi-drug Resistant Diarrhoea'; Dr Jiban Jyoti Panda, Associate Professor, Institute of Nano Science and Technology, Mohali spoke on 'Brain targeting Small Molecular Nanomedicines', Prof. Biman B. Mandal, Professor, IIT Guwahati shared his views on 'Nano-Composite Silk Hydrogel for Spatiotemporal, Targeted and On-Demand Controlled Release of Chemotherapeutics: An In Vivo Approach toward Suppressing Solid Tumour Growth', This session was chaired by Prof. Swaminathan, Professor & Director, SASTRA University.

Dr Praveen Kumar Vemula, Faculty, DBT INSTEM chaired a second session on Nano in Healthcare in which Prof. Neetu Singh, Professor & Head, Center for Biomedical Engineering, Indian Institute of Technology Delhi shared her views on the topic '3D Liver Platforms For In-Situ Disease Staging' and in his presentation Prof. Bikramjit Basu, Professor, IISc Bangalore touched upon 'Size-tailored Gold Nanoparticles: Novel electroactuators to guide stem cell differentiation and as bacteriotoxic agents' and Prof. K. Uma Maheswari, Professor, Sastra University spoke on Smart Non-intervention for Therapy.

Dr Taslimarif Syed, CEO and Director, C- CAMP, moderated a panel discussion on 'Healthcare & Medical Electronics' with Dr Aditya Kulkarni,

MORE STORIES FROM Bio Spectrum

Bio Spectrum

Bio Spectrum

Syngene strengthens leadership team with 2 key appointments

Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), has announced the appointment of Maninder Kapoor Puri as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief Commercial Officer (CCO), effective May 1, 2026.

time to read

1 min

June 2026

Bio Spectrum

NIScPR signs MoU with RIS to strengthen science, technology, innovation, policy and diplomacy

To strengthen cooperation in the fields of science, technology, innovation, policy, and diplomacy, the National Institute of Science Communication and Policy Research (NISCPR) has signed a Memorandum of Understanding with the Research and Information System for Developing Countries (RIS).

time to read

1 min

June 2026

Bio Spectrum

Bio Spectrum

Gaurav Jain steps into COO role at Redcliffe Labs

Redcliffe Labs has announced that Gaurav Jain has taken on the role of Chief Operating Officer (COO), marking a key leadership milestone as the company continues to scale its operations and strengthen its technology-led, consumer-first diagnostics ecosystem to make preventive diagnostics more accessible, affordable, accurate, and actionable across India.

time to read

1 min

June 2026

Bio Spectrum

ABEC expands Process Sciences Group to strengthen bioprocess optimisation capabilities

ABEC, a global leader in bioprocess engineering solutions, has announced the expansion of its Process Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the bioprocess lifecycle.

time to read

1 min

June 2026

Bio Spectrum

Bio Spectrum

Amneal Pharma buys Kashiv BioSciences to create fully integrated global biosimilar leader

Kashiv BioSciences has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals, Inc.

time to read

1 min

June 2026

Bio Spectrum

Bio Spectrum

Health Ministry unveils comprehensive guidance document on Diabetes Mellitus in children

In a historic step towards strengthening child health services, the Ministry of Health and Family Welfare has released the guidance document on Diabetes Mellitus in children.

time to read

1 min

June 2026

Bio Spectrum

Bio Spectrum

“We want to develop mRNA vaccines for the most prevalent cancers in India”

A unique initiative of the Tata Trusts with a mission to support the application of cutting-edge science to solve societal problems, Bengaluru-based Tata Institute for Genetics and Society (TIGS) is deepening its efforts towards developing science-based solutions to prevent diseases and improve access to affordable and quality diagnostics and therapeutics in the country.

time to read

5 mins

June 2026

Bio Spectrum

Bio Spectrum

Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1

Hyderabad-based Neuland Laboratories, a global contract development and manufacturing organisation (CDMO) specialising in complex APIs, has entered into a development partnership with LIR Life Sciences Corp, a Canada-based biotechnology company focused on scalable and accessible obesity treatments, in advancing its cell-penetrating peptide (CPP) platform.

time to read

1 min

June 2026

Bio Spectrum

Bio Spectrum

IIT Madras announces $7.5 M Menlo Park deep-tech hub to drive Indian innovation into Silicon Valley

Indian Institute of Technology (IIT) Madras Global Research Foundation has announced the establishment of its first centre in the United States (US), located in Menlo Park, California, marking a significant milestone in expanding India's deep-tech innovation footprint into global ecosystems.

time to read

1 min

June 2026

Bio Spectrum

Bio Spectrum

Oxford and Serum Institute of India to advance development of new malaria vaccine candidate

The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.

time to read

1 min

June 2026

Listen

Translate

Share

-
+

Change font size